Thirty-five states have agreed to participate in a federal pilot program aimed at helping Medicaid patients access costly ...

Sickle cell conditions are genetic blood disorders that affect haemoglobin, the molecule in red blood cells responsible for carrying oxygen throughout the body. While both sickle cell trait and ...

Unlimited access to all stories from nashuatelegraph.com on your computer, tablet or smart phone. Access nashuatelegraph.com, view our digital edition or use our Full ...

People with sickle cell disease are immunocompromised, which means they have an increased risk of infection. For this reason, immunizations are an important part of complete sickle cell care. This ...

Sickle cell disease experts are worried that recent staffing changes at the Centers for Disease Control and Prevention will impact a program that collects data about the genetic disease and how ...

Dear Dr. Roach: I was recently at the American Red Cross to donate blood and was given interesting material on the need for Black blood donors for sickle cell anemia patients. The booklet ...

Learn more. DEAR DR. ROACH: I was recently at the American Red Cross to donate blood and was given interesting material on the need for Black blood donors for sickle cell anemia patients.

Currently, diagnosing SCD requires expensive tools like high-performance liquid chromatography (HPLC), which limits early detection in large populations.

The CDC’s Division of Blood Disorders ran the Sickle Cell Data Collection program, which assessed the long-term trends of treatment and access to health care for people living with sickle cell ...

It has been known how immediate erythroid precursors ... Hydroxyurea Significantly Reduces Infections in Children With Sickle Cell Anemia Jan. 29, 2024 — Researchers have revealed that ...

Scientists at Raman Research Institute (RRI) have developed an affordable electro-fluidic device that aids in preliminary screening of Sickle Cell Disease (SCD). According to RRI, the innovative ...

Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of Lyfgenia (lovotibeglogene autotemcel), Bluebird’s gene therapy for sickle cell disease, incorporating ...